Quantitative Analysis of HER2 Amplification by Droplet Digital PCR in the Follow-Up of Gastric Cancer Patients Being Treated with Trastuzumab after Surgery
Background. Circulating tumor DNA (ctDNA) derived from tumors is a promising biomarker for monitoring tumor status and evaluating therapeutic effects and prognosis. We studied the plasma human epidermal growth factor receptor 2 (HER2) amplification in gastric cancer (GC) patients by droplet digital...
Saved in:
| Main Authors: | Yanzhuo Liu, Maozhu Yang, Tao Jiang, Chunbin Lan, Hao Yuan, Guiquan Li, Guiqing Jia, Kang Wang, Gaoping Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Gastroenterology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2019/1750329 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan
by: Negar Pourjamal, et al.
Published: (2025-03-01) -
Loss of HER2 Positivity after Trastuzumab in HER2-Positive Gastric Cancer: Is Change in HER2 Status Significantly Frequent?
by: Yu Ishimine, et al.
Published: (2015-01-01) -
Determination of HER2 amplification status on tumour DNA by digital PCR.
by: Isaac Garcia-Murillas, et al.
Published: (2013-01-01) -
Quantitative evaluation of the molecular marker using droplet digital PCR
by: Wonseok Shin, et al.
Published: (2020-03-01) -
A Case of Ventricular Arrhythmia in a Patient With HER2-Positive Gastric Cancer Receiving Trastuzumab
by: Naoto Takahashi, et al.
Published: (2025-01-01)